1Weidner N ,Semple J P , Welch WR et al . Tumor angiogenesis and metastasis correlation in invasive breast carcinoma[ J ]. N Engl J Med, 1991,324(1) :1-8.
2Cross M J, Claesson Welsh L. FGF and VEGF function in angiogenesis : Signalling pathways, biological response and therapouticinhibtion[J]. Trends Pharmacol Sci, 2001,22(4) :201-204.
6Takigawa N,Segawa Y, Fujimoto N, et al. Elevated vascular endothelial growth factor levels in sera of patients with lung caneer[J]. Anticancer Res, 1998,18 (28) : 1251-1254.
7Fetrara N, Henzel W J. Pituitary follicula cells secrete a novel heparin-hinding growth factor specific for vascular endothelial cells [J]. Biochem Biophys Res Commun,1989 ,161 (2) :851-858.
8Zhu Z, Witte L. Inhibition of tumor growth and metastasis by targeting tumor associated angiogenesls with antagonists to the receptors of vascular endosthelial growth factor[ J]. Invest New Drugs,1999, 17(3) :195-212.
3SHINKAI K,AKEDO H,MUKAI M.Inhibition of in vitro tuMor cell invasion by ginsenoside Rg3[J].Jpn J Cancer Res,1996,87(4):357.
4MOCHIZUKI M.YUNG CY.KAORI M.Inhibition effect of tuMor Metastasis in Mice by saponins,ginsenoside-Rb2,20(R)-and 20(S)-ginsenoside-Rg3,of red ginseng[J].BiolpharM Bull,1995,18(9):1197.
5IISHI H.TATSUTA M.BABA M.Inhibition by ginsenosideRg3 of boM besin-enhanced peritoneal Metastasis of intestiMaladenocarcinoMas induced by azoxyM ethane in Wistar rats[J].Clin Exp Metastasis,1997,15(6):603.
6WALTENBERGER j.MAYR U.FRANK H.SuraMin is a potentinhibitor of vascular endothelial growth factor.A contribution to the Molecular basis of its antiangionenic action.J Mol Cell Cardiol,1996,28(7):1523.
7SOHN KH,LEE HY,CHUNG HY.Anti-angiogen cactivity of triterpeneaci ds[J].Cancer Lett,1995,94～213.
8FOLKMAN J.Angiogenesis in cancer,vascular,rheuMatoid and other disease[J].Nature Med,1995,1:27.
